SCOPUS 정보 검색 플랫폼

Volumn 129, Issue 9, 2009, Pages 2299-2302

Double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacologic effect of CP-690,550 in patients with psoriasis

(10) Boy, Mary G a Wang, Cunshan b Wilkinson, Bethanie E b Chow, Vincent Fung Sing b Clucas, Alan T b Krueger, James G c Gaweco, Anderson S b Zwillich, Samuel H b Changelian, Paul S b Chan, Gary b

a PFIZER INC (United States)

b PFIZER GLOBAL RESEARCH AND DEVELOPMENT (United States)

c ROCKEFELLER UNIVERSITY (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [N [1 (2 CYANO 1 OXOETHYL) 4 METHYL 3 PIPERIDINYL] N METHYLAMINO]PYRROLO[2,3 D]PYRIMIDINE; JANUS KINASE 3;

CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG INDUCED HEADACHE; HEART ATRIUM FIBRILLATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; LETTER; LYMPHOCYTIC INFILTRATION; NAUSEA; PRIORITY JOURNAL; PSORIASIS; SINGLE BLIND PROCEDURE;

ADULT; BIOPSY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HUMANS; MIDDLE AGED; PSORIASIS; PYRIMIDINES; PYRROLES;

EID: 70349736206 PISSN: 0022202X EISSN: 15231747 Source Type: Journal
DOI: 10.1038/jid.2009.25 Document Type: Letter

Times cited : (133)

References (6)

1
- 7244220019
- JAK3 inhibition, a viable new modality of immunosuppression for solid organ transplants
- Borie DC, O?Shea JJ, Changelian PS (2004) JAK3 inhibition, a viable new modality of immunosuppression for solid organ transplants. Trends Mol Med 10:532-541
- (2004) Trends Mol Med , vol.10 , pp. 532-541
- Borie, D.C.¹ Oshea, J.J.² Changelian, P.S.³

2
- 0242332186
- Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor
- Changelian PS, Flanagan ME, Ball DJ, Kent CR, Magnuson KS, Martin WH et al. (2003) Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor. Science 302:875-878
- (2003) Science , vol.302 , pp. 875-878
- Changelian, P.S.¹ Flanagan, M.E.² Ball, D.J.³ Kent, C.R.⁴ Magnuson, K.S.⁵ Martin, W.H.⁶

3
- 0347949518
- Immunopathogenic mechanisms in psoriasis
- Gudjonsson JE, Johnston A, Sigmundsdottir H, Valdimarsson H (2004) Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 135:1-8
- (2004) Clin Exp Immunol , vol.135 , pp. 1-8
- Gudjonsson, J.E.¹ Johnston, A.² Sigmundsdottir, H.³ Valdimarsson, H.⁴

4
- 14244258610
- Psoriasis patho-physiology: Current concepts of pathogen-esis
- Krueger JG, Bowcock A (2005) Psoriasis patho-physiology: current concepts of pathogen-esis. Ann Rheum Dis 64(Suppl 2):ii30-6
- (2005) Ann Rheum Dis , vol.64 , Issue.SUPPL. 2
- Krueger, J.G.¹ Bowcock, A.²

5
- 13144260650
- Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs
- Pesu M, Candotti F, Husa M, Hofmann SR, Notarangelo LD, O?Shea JJ (2005) Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs. Immunol Rev 203:127-142
- (2005) Immunol Rev , vol.203 , pp. 127-142
- Pesu, M.¹ Candotti, F.² Husa, M.³ Hofmann, S.R.⁴ Notarangelo, L.D.⁵ Oshea, J.J.⁶

6
- 0034663951
- Inhibition of keratinocyte apoptosis by IL-15: A new parameter in the pathogenesis of psoriasis?
- Ruckert R, Asadullah K, Seifert M, Budagian VM, Arnold R, Trombotto C et al. (2000) Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis? J Immunol 165:2240-2250
- (2000) J Immunol , vol.165 , pp. 2240-2250
- Ruckert, R.¹ Asadullah, K.² Seifert, M.³ Budagian, V.M.⁴ Arnold, R.⁵ Trombotto, C.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.